Head Lice Drug Market continues to expand with Arbor Pharmaceuticals receiving the U.S. FDA approval for its Sklice, an over-the-counter (OTC) skin lotion for the treatment of head lice

Head lice are a serious problem that many families face each year. Unfortunately, they are difficult to treat once they have set up a home in the hair. If left untreated, they can grow rapidly, causing serious damage to the hair. Head lice cannot be simply wiped away with a dirty cloth. With growing burden of head lice in both urban and rural areas, the demand for effective medications and treatment options has gone up massively. As per the Centers for Disease Control and Prevention (CDC), in the U.S., around 6 to 12 million lice infestations occur each year among children aged 3 to 11 years. Such a high incidence of lice infestations has increased the demand for necessary drugs. Hence, these factors can accelerate growth of the head lice drug market.

As far as regional impact, developed regions such as North America have gained robust traction in the head lice drug market. This is typically due to the fact that there is the high presence of a larger infestation pool and high child population. As per the Annie E. Casey Foundation (AECF), in 2011, the population of children aged 18 years and below in the U.S. reached 74.2 million. On the contrary, emerging regions such as Asia Pacific are exhibiting promising signs in the head lice drug market. This is due to improving healthcare infrastructure.

Recently, in October 2020, Arbor Pharmaceuticals received the U.S. Food and Drug Administration (FDA) approval for its Sklice, an over-the-counter (OTC) skin lotion for the treatment of head lice.

Head-Lice Drug Shampoos is another popular medication used for the treatment of lice. These shampoos have the active ingredient nyloorizole. Despite these advantages, lack of awareness regarding relevant products remains a major challenging factor in the head lice drug market. Besides, there is an overall low expenditure on healthcare in emerging economies, which potentially limits growth of the head lice drug market in the near future.

Head lice oil is one of the most commonly prescribed medications for the treatment of lice. However, it does not work for every person. In addition to being a very expensive treatment option, it can be hard to find a licensed doctor who will give you the prescription. Even though there is the high incidence of head lice cases, effective treatment products are easily available in the market. Since head lice is a common problem in both developed and emerging economies, an adequate treatment solution is readily available in respective countries, which could potentially stimulate growth of the head lice drug market in the near future.